Monday, July 27th, 2015

Prostate Cancer Tests To Be Staged During Rlc Clash At New Road

Prostate Cancer Tests To Be Staged During Rlc Clash At New Road

Worcestershire CCC will be the venue for free testing for men to see whether or not they suffer from prostate cancer during Thursday's Royal London One-Day Cup match with Yorkshire at New Road.

The testing will come under the umbrella of the Worcestershire Ambassadors – a group of individuals who have a common passion for the county of Worcestershire – and take place in the 1865 Lounge throughout the day.

The Ambassadors consist of leading figures in business, commerce, public sector, private sector and also sport – including Worcestershire duo Daryl Mitchell and Moeen Ali.

Worcestershire Ambassadors raise significant sums of money for various charities each year.

Current WA chairman Vince Hopkins said: "We raise about fifty thousand pounds a year for charities and it's prostate cancer this year.

"We are supporting a charity to test as many people in the county as we can.

"It costs about £25 per test so we have already given £5,000 into getting more people tested and this is just a start.

"We are going to have a testing at New Road on July 30 during the Royal London One-Day Cup match with Yorkshire.

"David Leatherdale (Worcestershire chief executive) has agreed to do that so we'll be doing free testing for people who turn up for the one-day game here.

"We will hopefully test over 200 men on the day to help raise awareness and hopefully save lives.

"We also want to raise over one million pounds to have a robotic machine for the surgery at the Alexandra Hospital in Redditch."

The 'Rory the Robot' Appeal aims to raise £1.6million for a da Vinci surgical system that will change the future of prostate cancer surgery in Worcestershire.

Although the state of the art surgical system will be based at the Alexandra Hospital, which is the county’s centre of excellence for urology, it will cater for patients across Worcestershire.

Prostate cancer claims the life of one man every hour and by 2030 will be the most common cancer.

In Worcestershire alone there are 2500 men surviving prostate cancer at any one time, with about 450 to 550 new prostate cancer cases diagnosed annually.

The technology will allow surgeons to remove tumours with more precision through five cuts around the prostate gland rather than open surgery.

With Rory’s assistance patients will benefit from minimal blood loss, decreased pain following surgery, lower risk of complications and improved recovery times.